Orthostatic Hypotension and Blood Pressure Variability in Persons Undergoing Hemodialysis
1 other identifier
observational
25
1 country
1
Brief Summary
High blood pressure is a risk factor for end-stage renal disease and is common in patients undergoing maintenance hemodialysis. Intradialytic hypotension is associated with an adverse prognosis. More knowledge is needed to identify patients at high risk for intradialytic hypotension and dialysis-associated hypotensive episodes. The aim of this observational single-center pilot study is to evaluate whether point-of-care ultrasound measurements may predict intradialytic hypotension and orthostatic blood pressure falls, in patients with chronic kidney disease who undergo maintenance hemodialysis.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for all trials
Started Apr 2024
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
March 24, 2024
CompletedFirst Posted
Study publicly available on registry
April 4, 2024
CompletedStudy Start
First participant enrolled
April 8, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 30, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
August 30, 2024
CompletedNovember 14, 2024
November 1, 2024
5 months
March 24, 2024
November 12, 2024
Conditions
Outcome Measures
Primary Outcomes (2)
Intra-dialytic systolic blood pressure fall of 20 mmHg or larger
Difference between pre-dialytic and intra-dialytic systolic blood pressure
Up to 1 week
Post-dialytic orthostatic systolic blood pressure fall of 20 mmHg or larger
Change between supine and upright systolic blood pressure
Up to 1 week
Eligibility Criteria
All patients (n=70) with chronic kidney disease who undergo maintenance hemodialysis at Vrinnevi Hospital in Norrköping, Sweden, will be invited to voluntarily participate in the study.
You may qualify if:
- Patient undergoing hemodialysis treatment at Vrinnevi Hospital, Norrköping Sweden
- Provision of written informed consent
- Ability to understand instructions and to participate in the investigations
You may not qualify if:
- Ongoing acute illness
- Hospitalization within 4 weeks prior to enrollment
- Unability to provide informed consent
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Vrinnevi Hospital
Norrköping, Östergötland County, Sweden
Study Officials
- PRINCIPAL INVESTIGATOR
Magnus O Wijkman, MD, PhD
Vrinnevi Hospital, Department of Internal Medicine, Section of Endocrinology and Diabetology
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- CROSS SECTIONAL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal Investigator, Medically Responsible Physician at the Section for Endocrinology and Diabetology
Study Record Dates
First Submitted
March 24, 2024
First Posted
April 4, 2024
Study Start
April 8, 2024
Primary Completion
August 30, 2024
Study Completion
August 30, 2024
Last Updated
November 14, 2024
Record last verified: 2024-11
Data Sharing
- IPD Sharing
- Will not share